July 10 (Reuters) – Fusen Pharmaceutical Co Ltd: * DOXAZOSIN MESYLATE EXTENDED-RELEASE TABLETS APPROVED FOR MARKETING IN CHINA Further company coverage:
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
SK Hynix shares jump in marquee US debut as AI euphoria persists
By Utkarsh Shetti July 10 (Reuters) - SK Hynix's U.S.-listed shares jumped 14% in their…
Warburg Pincus nears $7 billion deal for PANTHERx Rare, WSJ reports
July 10 (Reuters) - Private equity firm Warburg Pincus is nearing a deal to acquire…
Arab Parliament for Child launches fourth session programme in Sharjah
Sharjah [UAE], July 10 (ANI/WAM): The Arab Parliament for the Child (APC) will begin implementing…
